Literature DB >> 15249123

Regulation of human glucocorticoid receptor gene transcription by Sp1 and p53.

Tadashi Suehiro1, Tadafumi Kaneda, Yukio Ikeda, Kaoru Arii, Yoshitaka Kumon, Kozo Hashimoto.   

Abstract

The human glucocorticoid receptor (hGR) gene has several GC boxes in the promoter 1C region. We studied the effects of Sp1 and p53 on promoter 1C in HepG2 and HEK293 cells using luciferase (Lu) reporter assay. The results showed that the first GC box upstream of the transcription site activated the hGR promoter and over-expression of Sp1 obviously enhanced the activity. A mutant Lu-hGR vector, whose first GC box was defective, lost promoter activity nearly completely. Further, over-expression of p53 strongly suppressed the stimulating effect of Sp1 on hGR promoter activity. We concluded that Sp1 activates the hGR gene promoter, at least in part, by acting on the first GC box in promoter 1C, while p53 suppresses the transactivation by Sp1. These phenomena, demonstrated in cultured cells, may be important for the expression of hGR in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249123     DOI: 10.1016/j.mce.2004.05.005

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

1.  Potential of Environmental Enrichment to Prevent Transgenerational Effects of Paternal Trauma.

Authors:  Katharina Gapp; Johannes Bohacek; Jonas Grossmann; Andrea M Brunner; Francesca Manuella; Paolo Nanni; Isabelle M Mansuy
Journal:  Neuropsychopharmacology       Date:  2016-06-09       Impact factor: 7.853

2.  Increased frequency of the glucocorticoid receptor A3669G (rs6198) polymorphism in patients with Diamond-Blackfan anemia.

Authors:  Lilian Varricchio; James Godbold; Stuart A Scott; Carolyn Whitsett; Lydie Da Costa; Dagmar Pospisilova; Emanuela Garelli; Paola Quarello; Ugo Ramenghi; Anna Rita Migliaccio
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

3.  Antenatal hypoxia induces epigenetic repression of glucocorticoid receptor and promotes ischemic-sensitive phenotype in the developing heart.

Authors:  Fuxia Xiong; Thant Lin; Minwoo Song; Qingyi Ma; Shannalee R Martinez; Juanxiu Lv; Eugenia MataGreenwood; Daliao Xiao; Zhice Xu; Lubo Zhang
Journal:  J Mol Cell Cardiol       Date:  2016-01-09       Impact factor: 5.000

4.  Fetal hypoxia increases vulnerability of hypoxic-ischemic brain injury in neonatal rats: role of glucocorticoid receptors.

Authors:  Pablo J Gonzalez-Rodriguez; Fuxia Xiong; Yong Li; Jianjun Zhou; Lubo Zhang
Journal:  Neurobiol Dis       Date:  2014-02-07       Impact factor: 5.996

5.  Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor.

Authors:  Samantha H Murphy; Kotaro Suzuki; Michael Downes; Genevieve L Welch; Paul De Jesus; Loren J Miraglia; Anthony P Orth; Sumit K Chanda; Ronald M Evans; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 6.  One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor.

Authors:  Levin Böhlig; Karen Rother
Journal:  J Biomed Biotechnol       Date:  2011-03-08

7.  p53 cooperates with Sp1 to regulate breed-dependent expression of glucocorticoid receptor in the liver of preweaning piglets.

Authors:  Huafeng Zou; Zheng Jiang; Runsheng Li; Yimin Jia; Xiaojing Yang; Yingdong Ni; Ruqian Zhao
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

Review 8.  C2H2-Type Zinc Finger Proteins: Evolutionarily Old and New Partners of the Nuclear Hormone Receptors.

Authors:  Rafah Mackeh; Alexandra K Marr; Abeer Fadda; Tomoshige Kino
Journal:  Nucl Recept Signal       Date:  2018-10-24

9.  Breed-dependent transcriptional regulation of 5'-untranslated GR (NR3C1) exon 1 mRNA variants in the liver of newborn piglets.

Authors:  Huafeng Zou; Runsheng Li; Yimin Jia; Xiaojing Yang; Yingdong Ni; Rihua Cong; Paul D Soloway; Ruqian Zhao
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.